X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-01 | CGEM | Savill Corrine | Chief Business Officer | S - Sale+OE | $16.18 | -40,000 | 165,990 | -19% | -$647,200 | |||||
| D | 2024-01-29 | CGEM | Savill Corrine | Chief Business Officer | S - Sale+OE | $14.09 | -40,000 | 165,990 | -19% | -$563,600 | |||||
| DM | 2024-01-22 | CGEM | Savill Corrine | Chief Business Officer | S - Sale+OE | $12.31 | -40,000 | 165,990 | -19% | -$492,508 | |||||
2023-12-26 | CGEM | Ahmed Nadim | Pres, CEO | S - Sale | $9.24 | -4,272 | 111,550 | -4% | -$39,473 | ||||||
2023-12-21 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $8.50 | -1,860 | 56,191 | -3% | -$15,810 | ||||||
2023-12-21 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $8.50 | -1,400 | 44,133 | -3% | -$11,900 | ||||||
2023-12-21 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $8.50 | -1,920 | 83,919 | -2% | -$16,320 | ||||||
2023-12-21 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $8.50 | -1,145 | 87,582 | -1% | -$9,733 | ||||||
2023-12-18 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $8.22 | -386 | 58,051 | -1% | -$3,173 | ||||||
2023-12-18 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $8.22 | -238 | 88,727 | 0% | -$1,956 | ||||||
2023-12-18 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $8.22 | -290 | 45,533 | -1% | -$2,384 | ||||||
2023-12-18 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $8.22 | -398 | 85,839 | 0% | -$3,272 | ||||||
2023-12-12 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $7.81 | -1,926 | 86,237 | -2% | -$15,042 | ||||||
2023-12-12 | CGEM | Michaelson Jennifer | Chief Scientific Officer | S - Sale | $7.81 | -1,068 | 88,965 | -1% | -$8,341 | ||||||
2023-06-28 | CGEM | Ahmed Nadim | Pres, CEO | S - Sale | $11.40 | -759 | 115,822 | -1% | -$8,653 | ||||||
2023-06-20 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $12.94 | -387 | 58,437 | -1% | -$5,008 | ||||||
2023-06-20 | CGEM | Michaelson Jennifer | Chief Development Officer | S - Sale | $12.94 | -238 | 90,033 | 0% | -$3,080 | ||||||
2023-06-20 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $12.94 | -399 | 85,823 | 0% | -$5,163 | ||||||
2023-06-20 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $12.94 | -291 | 45,823 | -1% | -$3,766 | ||||||
2023-06-12 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $13.11 | -319 | 86,222 | 0% | -$4,182 | ||||||
2023-06-12 | CGEM | Michaelson Jennifer | Chief Development Officer | S - Sale | $13.11 | -176 | 90,271 | 0% | -$2,307 | ||||||
| DM | 2023-06-06 | CGEM | Michaelson Jennifer | Chief Development Officer | S - Sale+OE | $12.31 | -12,000 | 90,447 | -12% | -$147,729 | |||||
2023-05-23 | CGEM | Ahmed Nadim | Pres, CEO | S - Sale | $9.15 | -707 | 116,581 | -1% | -$6,469 | ||||||
2023-05-18 | CGEM | Michaelson Jennifer | Chief Development Officer | S - Sale | $8.76 | -239 | 90,447 | 0% | -$2,094 | ||||||
2023-05-18 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $8.76 | -394 | 58,824 | -1% | -$3,451 | ||||||
2023-05-18 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $8.76 | -291 | 46,114 | -1% | -$2,549 | ||||||
2023-05-18 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $8.76 | -399 | 86,541 | 0% | -$3,495 | ||||||
2023-05-12 | CGEM | Michaelson Jennifer | Chief Development Officer | S - Sale | $8.78 | -193 | 90,686 | 0% | -$1,695 | ||||||
2023-05-12 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $8.78 | -347 | 86,940 | 0% | -$3,047 | ||||||
2023-04-25 | CGEM | Ahmed Nadim | Pres, CEO | S - Sale | $10.59 | -716 | 117,288 | -1% | -$7,582 | ||||||
2023-04-18 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $10.71 | -392 | 59,218 | -1% | -$4,198 | ||||||
2023-04-18 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $10.71 | -398 | 87,287 | 0% | -$4,263 | ||||||
2023-04-18 | CGEM | Michaelson Jennifer | Chief Development Officer | S - Sale | $10.71 | -238 | 90,879 | 0% | -$2,549 | ||||||
2023-04-18 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $10.71 | -290 | 46,405 | -1% | -$3,106 | ||||||
2023-04-12 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $10.22 | -318 | 87,685 | 0% | -$3,250 | ||||||
2023-04-12 | CGEM | Michaelson Jennifer | Chief Development Officer | S - Sale | $10.22 | -176 | 91,117 | 0% | -$1,799 | ||||||
2023-03-20 | CGEM | Trigilio Jeffrey | CFO | S - Sale | $11.32 | -399 | 88,003 | 0% | -$4,517 | ||||||
2023-03-20 | CGEM | Jones Jeffrey Alan | Chief Medical Officer | S - Sale | $11.32 | -390 | 59,610 | -1% | -$4,415 | ||||||
2023-03-20 | CGEM | Michaelson Jennifer | Chief Development Officer | S - Sale | $11.32 | -238 | 91,293 | 0% | -$2,694 | ||||||
2023-03-20 | CGEM | Sumer Jacquelyn L | GC | S - Sale | $11.32 | -305 | 46,695 | -1% | -$3,453 | ||||||
2023-03-23 | CGEM | Ahmed Nadim | Pres, CEO | S - Sale | $10.51 | -706 | 118,004 | -1% | -$7,420 | ||||||
| D | 2022-11-25 | CGEM | Michaelson Jennifer | See Remarks | S - Sale+OE | $13.30 | -4,000 | 53,031 | -7% | -$53,200 | |||||
| D | 2022-09-27 | CGEM | Michaelson Jennifer | See Remarks | S - Sale+OE | $12.40 | -4,000 | 53,031 | -7% | -$49,600 | |||||
| M | 2022-08-02 | CGEM | F2 Vision Scs | 10% | S - Sale | $14.26 | -49,910 | 4,476,350 | -1% | -$711,676 | |||||
| D | 2022-07-25 | CGEM | Michaelson Jennifer | Chief Development Officer | S - Sale+OE | $14.51 | -8,000 | 53,031 | -13% | -$116,080 | |||||
| M | 2022-07-18 | CGEM | Savill Corrine | Acting Chief Business Officer | S - Sale | $15.18 | -20,000 | 149,615 | -12% | -$303,593 | |||||
2022-07-11 | CGEM | Savill Corrine | Acting Chief Business Officer | S - Sale | $13.33 | -40,000 | 169,615 | -19% | -$533,304 | ||||||
| M | 2022-06-21 | CGEM | F2 Bioscience I 2017 Ltd | 10% | S - Sale | $12.80 | -101,903 | 4,430,964 | -2% | -$1,304,816 | |||||
2022-06-06 | CGEM | Ahmed Nadim | Pres, CEO | P - Purchase | $12.40 | +8,090 | 8,090 | New | +$100,316 | ||||||
2022-06-01 | CGEM | Bvf Partners L P/il | 10% | P - Purchase | $11.00 | +751,396 | 364,161 | -194% | +$8,264,905 | ||||||
| M | 2022-05-12 | CGEM | F2 Vision Scs | 10% | S - Sale | $9.66 | -418,738 | 4,532,867 | -8% | -$4,045,791 | |||||
| M | 2022-05-12 | CGEM | Bvf Partners L P/il | 10% | P - Purchase | $9.07 | +1,109,900 | 319,415 | -140% | +$10,063,937 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |